Clinical trial
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are…
NCT00354302 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00354302 |
|---|---|
| Title | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial |
| Official title | The Influence of Five Years of Adjuvant Anastrozole or Exemestane on Bone Mineral Density In Postmenopausal Women With Primary Breast Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Osteoporosis |
| Intervention type | Dietary Supplement, Drug, Other, Procedure |
| Interventions | calcium carbonate, calcium citrate, cholecalciferol, alendronate sodium, calcium gluconate, risedronate sodium, laboratory biomarker analysis, dual x-ray absorptometry |
| Enrollment | 497 |
| Start date | Apr 24, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Jan 6, 2012 |
| First posted | Jul 20, 2006 |
| Last update posted | Apr 2, 2020 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: